Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: August 19, 2022

Alpharma Us Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ALPHARMA US PHARMS, and what generic and branded alternatives to ALPHARMA US PHARMS drugs are available?

ALPHARMA US PHARMS has sixty-one approved drugs.

Summary for Alpharma Us Pharms

US Patents:	0
Tradenames:	43
Ingredients:	40
NDAs:	61

Drugs and US Patents for Alpharma Us Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Us Pharms	CODAMINE	hydrocodone bitartrate; phenylpropanolamine hydrochloride	SYRUP;ORAL	075103-001	Sep 29, 2000		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Alpharma Us Pharms	HYDRAMINE	diphenhydramine hydrochloride	SYRUP;ORAL	070205-001	Jan 28, 1986		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Alpharma Us Pharms	ERYTHROMYCIN ETHYLSUCCINATE	erythromycin ethylsuccinate	SUSPENSION;ORAL	062200-002	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Alpharma Us Pharms	METHDILAZINE HYDROCHLORIDE	methdilazine hydrochloride	SYRUP;ORAL	087122-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Alpharma Us Pharms

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-002	Approved Prior to Jan 1, 1982	4,620,974	See Plans and Pricing
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-006	Approved Prior to Jan 1, 1982	4,620,974	See Plans and Pricing
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-004	Approved Prior to Jan 1, 1982	4,620,974	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

McKinsey

Moodys

Harvard Business School

Johnson and Johnson

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.